Bacteriophages and phage-derived products as antibacterial therapeutics

Bibliography

• ALANIS AJ: Resistance to antibiotics: are we in the post-antibiotic era? Arch. Med. Res. (2005) 36:697-705.
   PubMed Web of Science ®Google Scholar
• CLARKE T: Drug companies snub antibiotics as pipeline threatens to run dry. Nature (2003) 425:225.
   PubMedGoogle Scholar
• PROJAN SJ: Why is big pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. (2003) 6:427-430.
   PubMed Web of Science ®Google Scholar
• ROHWER F, EDWARDS R: The phage proteomic tree: a genome-based taxonomy for phage. J. Bacteriol. (2002) 184:4529-4535.
   PubMed Web of Science ®Google Scholar
• SUMMERS WC: Felix dHerelle and the Origins of Molecular Biology. Yale University Press, New Haven, USA (1999).
   Google Scholar
• MORTON HE, ENGLEY FB: The protective action of dysentry bacteriophage in experimental infections in mice. J. Bacteriol. (1945) 49:245-255.
   PubMed Web of Science ®Google Scholar
• ZAYTZEFF-JERN H, HOWES EL, MELENEY FL: Studies in bacteriophage. I. The behavior of the bacteriophage and the bacteria in the lesion after the treatment of acute Staphylococcus skin infections with bacteriophage. J. Lab. Clin. Med. (1934) 19:1257-1271.
   Google Scholar
• BRONFENBRENNER J, SULKIN SE: Bacteriophage therapy. II. Prophylactic and therapeutic effect of bacteriophage and of antivirus in experimental infections of the eye. J. Infect. Dis. (1939) 65:58-63.
   Google Scholar
• SULKIN SE, DOUGLASS DD, BRONFENBRENNER J: Bacteriophage therapy. IV. Effect of bacteriophage in experimental staphylococcal septicemia in rabbits. J. Infect. Dis. (1942) 70:92-95.
   Google Scholar
• KRUEGER AP, SCRIBNER EJ: Bacteriophage therapy. I. The bacteriophage, its nature and its therapeutic use. J. Am. Med. Assoc. (1941) 116:2160-2167.
   Google Scholar
• KRUEGER AP, SCRIBNER EJ: Bacteriophage therapy. II. The bacteriophage, its nature and its therapeutic use. J. Am. Med. Assoc. (1941) 116:2269-2277.
   Google Scholar
• SUMMERS WC: Bacteriophage therapy. Ann. Rev. Microbiol. (2001) 55:437-451.
   PubMed Web of Science ®Google Scholar
• ALISKY J, ICZKOWSKI K, RAPOPORT A, TROITSKY N: Bacteriophages show promise as antimicrobial agents. J. Infect. (1998) 36:5-15.
   PubMed Web of Science ®Google Scholar
• SMITH HW, HUGGINS MB: Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol. (1982) 128:307-318.
   PubMedGoogle Scholar
• SMITH HW, HUGGINS MB: Effectiveness of phages in treating experimental Escherichia coli diarrhoe in calves, piglets and lambs. J. Gen. Microbiol. (1983) 129:2659-2675.
   PubMedGoogle Scholar
• SOOTHILL JS: Treatment of experimental infections of mice with bacteriophages. J. Med. Microbiol. (1992) 37:258-261.
   PubMed Web of Science ®Google Scholar
• MERRIL CR, BISWAS B, CARLTON R et al.: Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA (1996) 93:3188-3192.
   PubMed Web of Science ®Google Scholar
• BISWAS B, ADHYA S, WASHART P et al.: Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. (2002) 70:204-210.
   PubMed Web of Science ®Google Scholar
• CERVENY KE, DEPAOLA A, DUCKWORTH DH, GULIG PA: Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect. Immun. (2002) 70:6251-6262.
   PubMed Web of Science ®Google Scholar
• MATSUZAKI S, YASUDA M, NISHIKAWA H et al.: Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J. Infect. Dis. (2003) 187:613-624.
   PubMed Web of Science ®Google Scholar
• BERCHIERI A, LOVELL MA, BARROW PA: The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol. (1991) 142:541-549.
   PubMed Web of Science ®Google Scholar
• GILL JJ, PACAN JC, CARSON ME et al.: Efficacy and pharmacokinetics of bacteriophage therapy in the treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob. Agents Chemother. (2006) 50:2912-2918.
   PubMed Web of Science ®Google Scholar
• CARLTON RM: Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. (Warsz.) (1999) 47:267-274.
   PubMedGoogle Scholar
• MATSUZAKI S, RASHEL M, UCHIYAMA J et al.: Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J. Infect. Chemother. (2005) 11:211-219.
   PubMed Web of Science ®Google Scholar
• HAGENS S, HABEL A, VON AHSEN U, VON GABAIN A, BLASI U: Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob. Agents Chemother. (2004) 48:3817-3822.
   PubMed Web of Science ®Google Scholar
• WESTWATER C, KASMAN LM, SCHOFIELD DA et al.: Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Antimicrob. Agents Chemother. (2003) 47:1301-1307.
   PubMed Web of Science ®Google Scholar
• FISCHETTI VA: Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol. (2005) 13:491-496.
   PubMed Web of Science ®Google Scholar
• NELSON D, LOOMIS L, FISCHETTI VA: Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc. Natl. Acad. Sci. USA (2001) 98:4107-4112.
   PubMed Web of Science ®Google Scholar
• CHENG Q, NELSON D, ZHU S, FISCHETTI VA: Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob. Agents Chemother. (2005) 49:111-117.
   PubMed Web of Science ®Google Scholar
• SCHUCH R, NELSON D, FISCHETTI VA: A bacteriolytic agent that detects and kills Bacillus anthracis. Nature (2002) 418:884-889.
   PubMed Web of Science ®Google Scholar
• ZIMMER M, VUKOV N, SCHERER S, LOESSNER MJ: The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl. Environ. Microbiol. (2002) 68:5311-5317.
   PubMed Web of Science ®Google Scholar
• YOONG P, SCHUCH R, NELSON D, FISCHETTI VA: Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J. Bacteriol. (2004) 186:4808-4812.
   PubMed Web of Science ®Google Scholar
• KIM WS, SALM H, GEIDER K: Expression of bacteriophage phiEa1h lysozyme in Escherichia coli and its activity in growth inhibition of Erwinia amylovora. Microbiology (2004) 150:2707-2714.
   PubMed Web of Science ®Google Scholar
• GEIER MR, TRIGG ME, MERRIL CR: Fate of bacteriophage lambda in non-immune germ-free mice. Nature (1973) 246:221-223.
   PubMed Web of Science ®Google Scholar
• MARKOISHVILI K, TSITLANADZE G, KATSARAVA R, MORRIS JG Jr, SULAKVELIDZE A: A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int. J. Dermatol. (2002) 41:453-458.
   PubMed Web of Science ®Google Scholar
• LEVERENTZ B, CONWAY WS, CAMP MJ et al.: Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. (2003) 69:4519-4526.
   Google Scholar
• MODI R, HIRVI Y, HILL A, GRIFFITHS MW: Effect of phage on survival of Salmonella enteritidis during manufacture and storage of cheddar cheese made from raw and pasteurized milk. J. Food Prot. (2001) 64:927-933.
   PubMed Web of Science ®Google Scholar
• GREER G: Bacteriophage control of foodborne bacteria. J. Food Prot. (2005) 68:1102-1111.
   PubMed Web of Science ®Google Scholar
• HUDSON JA, BILLINGTON C, CAREY-SMITH G, GREENING G: Bacteriophages as biocontrol agents in food. J. Food Prot. (2005) 68:426-437.
   PubMed Web of Science ®Google Scholar
• FOOD AND DRUG ADMINISTRATION: Food additives permitted for direct addition to food for human consumption; bacteriophage preparation. USA Federal Register (2006) 71:47729-47732.
   Google Scholar
• CARLTON RM, NOORDMAN WH, BISWAS B, DE MEESTER ED, LOESSNER MJ: Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul. Toxicol. Pharmacol. (2005) 43:301-312.
   PubMed Web of Science ®Google Scholar
• OBRADOVIC A, JONES J, MOMOL M, BALOGH B, OLSON S: Management of tomato bacterial spot in the field by foliar applications of bacteriophages and SAR inducers. Plant Dis. (2004) 88:736-740.
   PubMed Web of Science ®Google Scholar